title: PDLIM5 gene polymorphisms and short term antidepressant response in Chinese major depressive disorders.
abstract: Several investigations have suggested that PDLIM5 plays a key role in the pathophysiology of major depressive disorder (MDD), and that PDLIM5 might be a therapeutic target for the action of antidepressant. In this study, we sought to investigate whether variations of PDLIM5 gene sequence could predict response to antidepressants in MDD patients. We selected 3 SNPs (rs10008257, rs2433320, 2452600) of PDLIM5 gene, and performed an association analysis of PDLIM5 and the efficacy of fluoxetine treatment in 185 Han Chinese MDD patients. The results show that the rs2433320 of PDLIM5 gene are associated with fluoxetine therapeutic response in MDD patients (X(2) = 8.2960, df = 2, P = 0.0145) after correction with the Bonferroni multiple test, the HAMD score of the GG genotype group was significantly lower than that of the AA and AG genotype group at 1, 2, 4 and 6 weeks. The results support the idea that the PDLIM5 gene is likely to be involved in the antidepressant response in MDD.
authors.affiliation: Department of Psychiatry, Renmin Hospital, Wuhan University Wuhan, China ; Institute of Neuropsychiatry, Renmin Hospital, Wuhan University Wuhan, China.
authors.forename: Zhongchun
authors.initials: Z
authors.lastname: Liu
authors.forename: Fan
authors.initials: F
authors.lastname: Zhu
authors.forename: Lihua
authors.initials: L
authors.lastname: Yao
authors.forename: Can
authors.initials: C
authors.lastname: Yang
authors.forename: Ling
authors.initials: L
authors.lastname: Xiao
authors.forename: Junhong
authors.initials: J
authors.lastname: Zhu
authors.forename: Huiling
authors.initials: H
authors.lastname: Wang
authors.forename: Gaohua
authors.initials: G
authors.lastname: Wang
authors.forename: Wanhong
authors.initials: W
authors.lastname: Liu
authors.forename: Zheman
authors.initials: Z
authors.lastname: Xiao
keywords: PDLIM5; antidepressant; major depressive disorder; pharmacogenetics
references.citation: J Clin Psychiatry. 2005 Aug;66(8):974-81
references.pmid: 16086611
references.citation: Neurosci Lett. 2006 Jun 12;400(3):203-7
references.pmid: 16595163
references.citation: Cell Signal. 2006 Feb;18(2):215-24
references.pmid: 15979848
references.citation: Hum Psychopharmacol. 2001 Jan;16(1):71-80
references.pmid: 12404601
references.citation: Br J Soc Clin Psychol. 1967 Dec;6(4):278-96
references.pmid: 6080235
references.citation: Psychiatr Genet. 2012 Aug;22(4):214-5
references.pmid: 21934642
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2005 May 5;135B(1):85-93
references.pmid: 15806581
references.citation: Neuropsychopharmacol Hung. 2012 Jun;14(2):87-101
references.pmid: 22710850
references.citation: Nat Neurosci. 2003 May;6(5):468-75
references.pmid: 12665800
references.citation: J Psychiatry Neurosci. 2009 May;34(3):199-204
references.pmid: 19448850
references.citation: Psychopharmacol Bull. 1996;32(1):27-32
references.pmid: 8927671
references.citation: Am J Psychiatry. 2006 Nov;163(11):1905-17
references.pmid: 17074942
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2002 Feb;26(2):383-6
references.pmid: 11817517
references.citation: J Mol Med (Berl). 2007 Jun;85(6):555-68
references.pmid: 17294230
references.citation: J Psychiatry Neurosci. 2008 Jan;33(1):43-6
references.pmid: 18197271
references.citation: Mol Psychiatry. 2005 Nov;10(11):1045-55
references.pmid: 16044170
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2003 Aug 15;121B(1):21-7
references.pmid: 12898570
references.citation: J Hum Genet. 2004;49(5):227-31
references.pmid: 15362566
references.citation: J Hum Genet. 1999;44(4):256-60
references.pmid: 10429367
references.citation: Neurosci Lett. 2007 Mar 6;414(2):155-8
references.pmid: 17258395
references.citation: Expert Rev Neurother. 2011 Jan;11(1):101-25
references.pmid: 21158559